97 related articles for article (PubMed ID: 3057569)
1. [The place of tumor markers in breast and gynecologic neoplasms].
Gosselin P; Cazin JL; Demaille MC; Sulman C
Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
4. [Gynecologic malignancies].
Kato H
Nihon Rinsho; 1996 Jun; 54(6):1637-41. PubMed ID: 8691622
[TBL] [Abstract][Full Text] [Related]
5. [Squamous cell carcinoma antigen--a useful tumor marker for gynecologic squamous cell cancers?].
Neunteufel W; Tatra G; Reinthaller A; Bieglmayer C
Gynakol Rundsch; 1988; 28 Suppl 2():201-2. PubMed ID: 3234918
[No Abstract] [Full Text] [Related]
6. [General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer].
Kreienberg R
Gynakologe; 1989 Feb; 22(1):55-62. PubMed ID: 2653979
[No Abstract] [Full Text] [Related]
7. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
9. [T antigen and CEA; comparison between 2 tumor markers in breast cancer and malignant gynecologic neoplasms].
Scheiffarth OF
Arch Gynecol; 1979 Jul; 228(1-4):659-60. PubMed ID: 485546
[No Abstract] [Full Text] [Related]
10. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
Ulsperger E; Karrer K
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():33-43. PubMed ID: 3074225
[No Abstract] [Full Text] [Related]
11. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of carcinoembryonic antigen (CEA) and serum and tissue alpha-fetoprotein (AFP) in malignant tumors of the female genital tract].
Tolino A; Di Serio C; Borruto Caracciolo G; Giamberini S; Montemagno U
G Ital Oncol; 1989; 9(2-3):63-6. PubMed ID: 2475441
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.
Sterns EE; Cochran AJ
Surg Gynecol Obstet; 1989 Jul; 169(1):81-98. PubMed ID: 2662454
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
15. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
16. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers in gynecology].
Fuith LC; Artner-Dworzak E; Daxenbichler G
Wien Klin Wochenschr; 1989 Jul; 101(14):489-91. PubMed ID: 2672608
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers and their use in gynecologic oncology].
Durdević S; Segedi D
Med Pregl; 1989; 42(11-12):457-60. PubMed ID: 2642208
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers in gynecology. General review].
Briese V; Strache RR
Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values].
Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M
Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
